We are live on ! Find out more
BGA

Belmont Global Advisors Portfolio holdings

AUM $106M
1-Year Est. Return 2.89%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
-2.89%
3 Year Est. Return
+81.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$1.54M
Cap. Flow
+$1.48M
Cap. Flow %
1.4%
Top 10 Hldgs %
66.08%
Holding
96
New
32
Increased
14
Reduced
12
Closed
27

Top Buys

Rank Stock Value
1
TCRT icon
Alaunos Therapeutics
TCRT
+$2.18M
2
IMPV
Imperva, Inc.
IMPV
+$1.32M
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$1.08M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$1.06M
5
BBW icon
Build-A-Bear
BBW
+$979K

Top Sells

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.29M
2
HD icon
Home Depot
HD
+$1.28M
3
PANW icon
Palo Alto Networks
PANW
+$1.04M
4
LJPC
La Jolla Pharmaceutical Company
LJPC
+$960K
5
CHKP icon
Check Point Software Technologies
CHKP
+$797K

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.6%
2 Healthcare 26.08%
3 Technology 7.28%
4 Consumer Discretionary 3.69%
5 Industrials 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRT icon
1
CALL
Alaunos Therapeutics
TCRT
$4.19M
$15.7M 14.83%
18,561
+2,528
+16% +$2.03M
PGEN icon
2
CALL
Precigen
PGEN
$2.56B
$12.7M 12.06%
459,095
-20,180
-4% -$534K
TCRT icon
3
Alaunos Therapeutics
TCRT
$4.19M
$12.5M 11.85%
14,835
+2,715
+22% +$2.18M
QQQ icon
4
PUT
Invesco QQQ Trust
QQQ
$488B
$11.9M 11.23%
+100,000
New +$11.5M
PGEN icon
5
Precigen
PGEN
$2.56B
$8.42M 7.97%
303,255
+20,180
+7% +$534K
MNDT
6
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
$2.21M 2.09%
+150,000
New +$2.3M
VBTX
7
DELISTED
Veritex Holdings
VBTX
$1.66M 1.57%
95,404
+1,175
+1% +$20K
FBIO icon
8
Fortress Biotech
FBIO
$90.4M
$1.62M 1.53%
36,333
-334
-0.9% -$14.2K
ACAD icon
9
CALL
Acadia Pharmaceuticals
ACAD
$4.8B
$1.59M 1.51%
50,000
-100,000
-67% -$3.39M
IMPV
10
DELISTED
Imperva, Inc.
IMPV
$1.53M 1.45%
+28,500
New +$1.32M
SGYP
11
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.49M 1.41%
270,000
-115,000
-30% -$538K
AMZN icon
12
Amazon
AMZN
$2.79T
$1.26M 1.19%
30,160
– –
AIRM
13
CALL
DELISTED
Air Methods Corp
AIRM
$1.26M 1.19%
+40,000
New +$1.36M
MNDT
14
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1.19M 1.13%
81,000
+21,000
+35% +$323K
GLD icon
15
SPDR Gold Trust
GLD
$150B
$1.18M 1.12%
9,265
+7,415
+401% +$944K
MSFT icon
16
Microsoft
MSFT
$3.79T
$1.16M 1.09%
20,055
– –
BDSI
17
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.15M 1.09%
+425,000
New +$1.08M
CYTK icon
18
CALL
Cytokinetics
CYTK
$10.3B
$1.1M 1.04%
+120,000
New +$1.25M
SGYP
19
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.1M 1.04%
+200,000
New +$936K
BHK icon
20
BlackRock Core Bond Trust
BHK
$647M
$1.07M 1.01%
75,069
+1,455
+2% +$20.5K
LXU icon
21
LSB Industries
LXU
$809M
$1.03M 0.97%
156,000
+104,000
+200% +$884K
ALNY icon
22
Alnylam Pharmaceuticals
ALNY
$35.4B
$1.02M 0.96%
+15,000
New +$1.06M
META icon
23
Meta Platforms (Facebook)
META
$1.56T
$1.01M 0.95%
7,860
+160
+2% +$19.9K
ORLY icon
24
O'Reilly Automotive
ORLY
$70.7B
$984K 0.93%
52,680
– –
OSPN icon
25
OneSpan
OSPN
$617M
$880K 0.83%
+50,000
New +$879K
1
2 3 4

Similar funds

LOT
Lombard Odier Transatlantic Montreal, Quebec, Canada $105M AUM 10.28% 1-Year Est. Return
EC
Eachwin Capital New York $108M AUM 14.45% 1-Year Est. Return
SAMNY
Samsung Asset Management (New York) New York $109M AUM 14.33% 1-Year Est. Return
DCMM
DG Capital Management (Massachusetts) Boston, Massachusetts $102M AUM 29.14% 1-Year Est. Return
PCM
Panning Capital Management New York $97.5M AUM 302.5% 1-Year Est. Return
SVGI
Sapphire Ventures (GPE) I Palo Alto, California $115M AUM 11.63% 1-Year Est. Return
EDRM
Edmond de Rothschild (Monaco) Monaco $116M AUM
EDRAML
Edmond de Rothschild Asset Management (Luxembourg) Luxembourg $95.2M AUM 19.45% 1-Year Est. Return

Belmont Global Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Belmont Global Advisors held 96 positions worth $106M, up 1.5% from $104M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Belmont Global Advisors's Q3 2016 filing shows 32 new, 14 increased, 12 reduced and 27 closed positions. Its largest new stake was Imperva, Inc.: 28,500 shares worth $1.53M. The largest sale was Acadia Pharmaceuticals, an estimated $1.29M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 56% a quarter earlier, followed by Healthcare and Technology.

  • Belmont Global Advisors's largest Q3 2016 buy was Imperva, Inc.: 28,500 shares worth $1.53M.
  • Belmont Global Advisors added most to Alaunos Therapeutics in Q3 2016, an estimated $2.18M increase.
  • Belmont Global Advisors's biggest Q3 2016 reduction was Fate Therapeutics, cutting an estimated $607K.
  • Belmont Global Advisors fully exited Acadia Pharmaceuticals in Q3 2016, selling an estimated $1.29M.
  • Belmont Global Advisors's ten largest holdings make up 66% of its $106M portfolio in Q3 2016.
  • Belmont Global Advisors opened 32 new positions and closed 27 in Q3 2016.
  • Belmont Global Advisors's portfolio value rose 1.5% quarter-over-quarter to $106M.

Based on Belmont Global Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.